Dechra Pharmaceuticals PLC Director/PDMR Shareholding (6654C)
October 20 2020 - 6:01AM
UK Regulatory
TIDMDPH
RNS Number : 6654C
Dechra Pharmaceuticals PLC
20 October 2020
20 October 2020
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Grant of SAYE options:
Dechra Pharmaceuticals PLC announces that on 19 October 2020 the
following PDMRs were granted options over ordinary shares of 1p
each in the Company pursuant to the Dechra Global Save As You Earn
Plan 2018 (the Options).
The Options have been granted with an exercise price of
GBP28.68.
Name Capacity Options Granted
Ian Page Director 627
Paul Sandland Director 627
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
------------------------------------ -------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------ -------------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------ -------------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------ -------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------ -------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------ -------------------------------------------
b) Nature of the Grant of 627 options under the Company's
transaction Save As You Earn Scheme
------------------------------------ -------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP28.68 627
------------------------------------ --------------------- --------------------
d) Aggregated information
* Aggregate volume
627
GBP17,982.36
* Price
------------------------------------ -------------------------------------------
e) Date of the transaction 2020.10.19
------------------------------------ -------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------ -------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Paul Sandland
------------------------------------ -------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------ -------------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------ -------------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------ -------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------ -------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------ -------------------------------------------
b) Nature of the Grant of 627 options under the Company's
transaction Save As You Earn Scheme
------------------------------------ -------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP28.68 627
------------------------------------ --------------------- --------------------
d) Aggregated information
* Aggregate volume
627
GBP17,982.36
* Price
------------------------------------ -------------------------------------------
e) Date of the transaction 2020.10.19
------------------------------------ -------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------ -------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, marketing and sales of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHKKKBPKBDDCKB
(END) Dow Jones Newswires
October 20, 2020 07:01 ET (11:01 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024